Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Oculex dexamethasone intraocular delivery system superior to eye drops

Nov. 20, 1996

InSite Vision strengthens position on genetic research into glaucoma

Nov. 1, 1996

Hybridon's VEGF-targeting antisense drugs for retinal neovascularization

Nov. 1, 1996

Ciba Vision licenses novel antiglaucoma agent from Ueno

Oct. 25, 1996

Revolutionary treatment for nearsightedness enters pivotal trials

Oct. 18, 1996

Sugen-Allergen collaboration in ophthalmic diseases

Oct. 18, 1996

New use for Uriach's rupatadine

Oct. 11, 1996

Anticataract and NGF production-enhancing compounds

Sep. 27, 1996

Wakamoto claims diclofenac eyedrop formulation

Sep. 20, 1996

AGN-193080, a peripherally acting alpha2-agonist from Allergan

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...